TrialDrugs in R&D2024

Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions.

Manuel Román et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.